Barry E. Greene, President and COO at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 11,200 shares at $100.00 ($1.1M) on 2014-12-19, disclosed to the SEC on 2014-12-22.
Scheduled sale ($1.1M) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SAGE | BUY | 2021-06-17 | $496K | — | Filing → |
| ALNY | SELL | 2020-09-11 | $11.0M | — | Filing → |
| ALNY | SELL | 2020-07-09 | $7.1M | — | Filing → |